Eikon Therapeutics, Inc. · NASDAQ:EIKN
FMR LLC reported a 9.20% stake in Eikon Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 6, 2026
FMR LLC reported a 9.20% stake in Eikon Therapeutics, Inc., 4,993,906 shares, as a passive investor on Jun 30, 2026. Filed Aug 6, 2026 (Schedule 13G/A).
- Stake
- 9.20%
- Shares
- 4,993,906
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 9.20% | 4,993,906 |
| Abigail P. Johnson | 9.20% | 4,993,906 |
Source
Related
- Eikon Therapeutics, Inc.
- FMR LLC
- Eikon Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G · FMR LLC · May 6, 2026
- Schedule 13G/A · Abu Dhabi Investment Authority · Oct 2, 2026
- Form 4 · Kutzkey Tim · Sep 8, 2026
- Schedule 13G · Innovation Endeavors III LP · May 15, 2026
- Schedule 13G · Perlmutter Roger M · May 13, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Apr 29, 2026